Clinical trial
Assessment of the Safety and Efficacy of the Danubio Paclitaxel-Eluting Balloon for the Treatment of Side Branches of de Novo Bifurcation Lesions in Native Coronary Arteries.
NCT01485081 is registered in ClinicalTrials.gov with MINVASYS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Safety and Efficacy of the Danubio Paclitaxel-Eluting Balloon for the Treatment of Side Branches of de Novo Bifurcation Lesions in Native Coronary Arteries.
- Lead sponsor
- MINVASYS
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- July 31, 2014
- Enrollment
- 52 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.